Nippon Shinyaku - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsNippon Shinyaku

Nippon Shinyaku

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Viltepso	Viltolarsen	2020-08-12	2031	Duchenne muscular dystrophy

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

duchenne muscular dystrophy

,

muscular dystrophies

Aglatimagene besadenovec

prostatic neoplasms

renal cell carcinoma

,

,

uterine cervical neoplasms

,

,

chronic hepatitis d

,

,

rheumatoid arthritis

,

,

,

,

chronic hepatitis c

,

chronic hepatitis

essential thrombocythemia

,

polycythemia vera

,

primary myelofibrosis

,

,

Microcrystalline cellulose

,

muscular atrophy

,

,

,

hiv-associated lipodystrophy syndrome

,

colorectal neoplasms

,

,

chronic obstructive pulmonary disease

,

ulcerative colitis

,

,

,

respiratory tract diseases

,

respiration disorders

,

multiple sclerosis

,

relapsing-remitting multiple sclerosis

,

,

,

,

healthy volunteers/patients

,

,

human influenza

,

,

falciparum malaria

,

,

multiple myeloma

,

plasma cell neoplasms

,

,

non-hodgkin lymphoma

,

precursor cell lymphoblastic leukemia-lymphoma

,

precursor t-cell lymphoblastic leukemia-lymphoma

,

large b-cell lymphoma diffuse

,

b-cell lymphoma

,

,

prehypertension

,

,

b-cell chronic lymphocytic leukemia

,

lymphoid leukemia

,

neisseria meningitidis

,

haemophilus infections

,

,

type 2 diabetes mellitus

,

,

,

diabetes mellitus

,

acquired immunodeficiency syndrome

,

,

immunologic deficiency syndromes

,

,

communicable diseases

,

,

,

,

haemophilus influenzae type b

,

,

renal insufficiency

,

,

,

,

,

,

chronic hepatitis b

,

,

chronic hepatitis

,

,

immunologic tests

Potassium magnesium citrate (4:1:2)

,

colorectal neoplasms

,

,

respiratory tract diseases

,

respiration disorders

,

multiple sclerosis

,

relapsing-remitting multiple sclerosis

,

,

,

human influenza

,

,

falciparum malaria

,

,

non-hodgkin lymphoma

,

precursor cell lymphoblastic leukemia-lymphoma

,

precursor t-cell lymphoblastic leukemia-lymphoma

,

large b-cell lymphoma diffuse

,

b-cell lymphoma

,

,

prehypertension

,

,

b-cell chronic lymphocytic leukemia

,

lymphoid leukemia

,

neisseria meningitidis

,

haemophilus infections

,

multiple myeloma

,

type 2 diabetes mellitus

,

,

,

diabetes mellitus

,

acquired immunodeficiency syndrome

,

,

,

communicable diseases

,

immunologic deficiency syndromes

,

,

,

,

haemophilus influenzae type b

,

,

renal insufficiency

,

,

,

,

,

,

immunologic tests

Potassium nitrate

,

colorectal neoplasms

,

,

,

respiratory tract diseases

,

respiration disorders

,

multiple sclerosis

,

relapsing-remitting multiple sclerosis

,

,

,

human influenza

,

hypersensitivity

,

dentin sensitivity

,

,

,

falciparum malaria

,

,

,

non-hodgkin lymphoma

,

precursor cell lymphoblastic leukemia-lymphoma

,

precursor t-cell lymphoblastic leukemia-lymphoma

,

large b-cell lymphoma diffuse

,

b-cell lymphoma

,

prehypertension

,

,

b-cell chronic lymphocytic leukemia

,

lymphoid leukemia

,

neisseria meningitidis

,

haemophilus infections

,

,

multiple myeloma

,

type 2 diabetes mellitus

,

,

,

diabetes mellitus

,

acquired immunodeficiency syndrome

,

,

,

communicable diseases

,

immunologic deficiency syndromes

,

,

,

,

haemophilus influenzae type b

,

,

renal insufficiency

,

,

,

,

,

,

immunologic tests

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use